Tunisia’s president orders military to manage virus crisis

Tunisia’s president orders military to manage virus crisis

A man wearing a face mask to protect from COVID-19 leaves a hospital in Tunis, Tunisia, Wednesday, July 21, 2021. Tunisia’s president on Wednesday ordered the military to take over management of the national COVID-19 pandemic response, as the country fights one of Africa’s worst outbreaks. (AP Photo/Hassene Dridi)

TUNIS, Tunisia (AP) — Tunisia’s president ordered the military Wednesday to take over managing the national COVID-19 pandemic response, as the country fights one of Africa’s worst outbreaks.

The military health service will be assigned the task, Tunisian President Kais Saied announced on regional TV network Al Arabiya.

Soldiers and military medics are already carrying out vaccinations in remote parts of Tunisia. On Tuesday, military trucks transported oxygen to regions in the center and northwest of the country where hospitals are suffering shortages.

Meanwhile, an interim health minister on Wednesday replaced the health minister who was fired over his surprise decision to open vaccination centers to all adults for the first time this week during the Muslim holiday Eid al-Adha.

Authorities were unprepared for the decision, which prompted confusion and chaos as crowds massed at vaccination centers. The president called it a “crime” to encourage large groups to gather while the government is trying to limit the spread of the virus.

Eid al-Adha, or the “Feast of Sacrifice,” is typically marked by communal prayers, large social gatherings, slaughtering of livestock and distributing meat to the needy. This year, Tunisian authorities restricted gatherings and reinstated a curfew in some regions with high numbers of confirmed cases.

In a new blow to Tunisia’s long-struggling tourism sector, authorities closed some of the country’s Mediterranean beaches.

The former health minister’s decision to open vaccination centers during the holiday led to confrontations at some locations between people seeking shots before doses ran out and health officials trying to enforce anti-infection measures.

Windows and doors of some vaccination centers were smashed, and medics and paramedics were assaulted in some places, oOpposition lawmaker Saifeddine Merghni, a medical doctor, said.

“The least that can be said is that the decision (to open vaccination centers on the Muslim feast day) is wrong, and you see its repercussions,” he said. “The day of joy (Eid Al-Adha) turned into a day of a lot of tension.”

People wearing face masks to protect from COVID-19, stand outside a hospital in Tunis, Tunisia, Wednesday, July 21, 2021. Tunisia’s president on Wednesday ordered the military to take over management of the national COVID-19 pandemic response, as the country fights one of Africa’s worst outbreaks. (AP Photo/Hassene Dridi)

The line at the only vaccination center in the central city of Kairouan was so long that 63-year-old Ali ben Haj was making his third try to get vaccinated and growing impatient.

“Look at all the people. Why all this? What have we done? You, authorities, if you cannot find solutions for us, let us search for solutions ourselves,” he said.

Overall, Tunisia has reported more deaths per capita than any African country and among the highest daily death rates per capita in the world in recent weeks. Foreign countries have been pouring in vaccines and other medical aid.

___

Mehdi El Arem contributed from Kairouan and Tunis.

 

Quality research in Africa matters more than ever – for the whole world

Quality research in Africa matters more than ever – for the whole world

We are at a unique moment in history. Two particular, ongoing events stand out. COVID-19 is one. The other is a long-overdue recognition of inequities among people in the US and worldwide, as exemplified by the Black Lives Matter movement. These issues provide a useful, timely lens through which to consider the role and value of African research.

There are many levels on which the future of the world, not just Africa’s, rests on African research. First, Africa represents the youngest and fastest growing population in the world. This makes intellectual investment an imperative, to harness talent that is a significant and growing share of the global population.

Second, Africans represent the oldest and most diverse genome in the world. Human genetics research has the potential to reveal some of the small differences in our genes that are influential in determining what makes Africa more susceptible or resistant to certain diseases. The findings can influence disease outcomes and response to treatment.

Such studies are critical not just to improve the health of Africans themselves, but also to shed light on diseases that affect people of African origin who reside all over the world.

Scientists around Africa are working at the cutting edge of research and their work is relevant beyond the continent.
PIUS UTOMI EKPEI/AFP via Getty Images

Third, Africa carries about 25% of the global disease burden. This is rapidly shifting from communicable to noncommunicable causes. Of course, it’s good news that part of this equation reflects a decline in death and illness from AIDS, malaria, tuberculosis and neglected tropical diseases.

But it is also a sad story of the rapid increase in incidence in the noncommunicable diseases that have for a long time dominated in the global North. Heart and other vascular diseases, cancer and diabetes in African countries are often driven by the same excesses that exist in societies that have been prosperous for longer: obesity, smoking, and lack of exercise. By investing in African science to address African diseases, we invest in the parallel prevention and treatment of the same diseases everywhere in the world.

Fourth, scientific research is a vital driver of economies. Currently, the African continent’s scientific output represents less than 2.6% of the world’s share, according to UNESCO. Without major investments in scientific research, particularly the kind of basic research that is often not considered cost-effective for private enterprises, African economies will be at a perpetual economic disadvantage.

All of this raises the question: is there world-class research in Africa? Yes, there is. Thanks to major investment in science infrastructure, human resource training and education, the continent is well placed to lead from the front.

World-class research

This investment has not happened by accident. It’s been driven by deliberate programs and advocacy, much of it through the Alliance for Accelerating Excellence in Science in Africa.

We and our colleagues at the African Academy of Sciences created the Alliance in 2015 through a partnership with the African Union Development Agency, founding and funding global partners, and through a resolution of the summit of African Union Heads of Governments. The Academy’s research and training programs operate under the Alliance. Its mission is to shift the centre of gravity for African science to Africa through setting agendas, mobilizing research and development funding, and managing science programs.

The Alliance for Accelerating Excellence in Science in Africa has funded 186 grantees directly. Some of them in turn offer master’s, PhD and postdoctoral fellowships. This has led to a scientific community numbering over 2,000 scientists in about 40 countries.

Among our premier programs are DELTAS Africa and Grand Challenges Africa. They tackle major infectious diseases, neglected tropical diseases and other health challenges.

These and other programs are bearing fruit. Research emerging from the Alliance includes point-of-care diagnostics; the reduction of carbon dioxide emissions and identifying novel genes to detect hearing impairment early.

All of this research can be applied in African countries and beyond. And more of it can be produced if the global scientific community, governments, funders and others come together to tackle the hurdles that African researchers still face.

Challenges

These challenges include:

  • Inequities within and among populations and between genders. These result in much potential talent being lost to science in general.
  • Exploitation by commercial enterprises that regard the African continent as a source of large populations for clinical trials.
  • Funding. Until more African science is predominantly performed in Africa, by Africans, and for Africans, the full potential of this work will never be realized.

The nations of the African Union have all pledged to dedicate 1% of their respective GDPs to research and development but spend an average of 0.45%. These nations are grappling with many competing needs.

Basic research is almost never attractive to commercial funders, and African governments often do not have the resources to fill this void. Or they are not in office long enough.

Western funders tend to focus on health and medical research. This is worthy. But it leaves the physical, mathematical, and chemical sciences as underfunded orphans. Big innovations are built on the foundation of basic discovery. African scientists must enjoy the opportunity to contribute to that foundation alongside their peers in countries where public investment in basic science has been provided for decades.

This article is adapted from a longer piece in ACS Omega, available here.The Conversation

This article is republished from The Conversation under a Creative Commons license. Read the original article.